Comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza A virus infection

Immunology

Volumn 120, Issue 3, 2007, Pages 380-391

  Rosseau, Simone ^a   Hocke, Andreas ^a   Mollenkopf, Hans ^b   Schmeck, Bernd ^a   Suttorp, Norbert ^a   Kaufmann, Stefan H E ^b   Zerrahn, Jens ^b,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^c PAREXEL INTERNATIONAL   (United States)

Author keywords

Influenza; Lung; Pneumococci; Pneumonia; Transcriptome

Indexed keywords

ANTIGEN; GENE PRODUCT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BACTERIAL VIRULENCE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS A; LOBAR PNEUMONIA; MOUSE; MULTIGENE FAMILY; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; UNINDEXED SEQUENCE;

ANIMALS; B-LYMPHOCYTES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, VIRAL; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, CELLULAR; INFLUENZA A VIRUS; LUNG; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 33846940079     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02514.x     Document Type: Article

References (49)

1. File TM. Community-acquired pneumonia. Lancet 2003; 362:1991-2001.
2. Shorr AF. Preventing pneumonia: the role for pneumococcal and influenza vaccines. Clin Chest Med 2005; 26:123-34.
3. Oliveira EC, Lee B, Colice GL. Influenza in the intensive care unit. J Intensive Care Med 2003; 18:80-91.
4. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006; 19:571-82.
5. Novak R, Tuomanen E. Pathogenesis of pneumococcal pneumonia. Semin Respir Infect 1999; 14:209-17.
6. Kadioglu A, Andrew PW. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol 2004; 25:143-9.
7. Lipatov AS, Govorkova EA, Webby RJ, Ozaki H, Peiris M, Guan Y, Poon L, Webster RG. Influenza: emergence and control. J Virol 2004; 78:8951-9.
8. Kash JC, Basler CF, Garcia-Sastre A et al. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J Virol 2004; 78:9499-511.
9. Schmeck B, Zahlten J, Moog K et al. Streptococcus pneumoniae- induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor. J Biol Chem 2004; 279:53241-7.
10. Debes GF, Bonhagen K, Wolff T, Kretschmer U, Krautwald S, Kamradt T, Hamann A. CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection. J Virol 2004; 78:7528-35.
11. Kadioglu A, Gingles NA, Grattan K, Kerr A, Mitchell TJ, Andrew PW. Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 2000; 68:492-501.
12. Liang S, Mozdzanowska K, Palladino G, Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol 1994; 152:1653-61.
13. Schmitz N, Kurrer M, Bachmann MF, Kopf M. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 2005; 79:6441-8.
14. Churchill GA. Fundamentals of experimental design for cDNA microarrays. Nat Genet 2002; 32 (Suppl. ):490-5.
15. Taylor SL, Renshaw BR, Garka KE, Smith DE, Sims JE. Genomic organization of the interleukin-1 locus. Genomics 2002; 79:726-33.
16. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, Kastner DL. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003; 11:591-604.
17. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004; 21:241-54.
18. Villarino AV, Huang E, Hunter CA. Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol 2004; 173:715-20.
19. Linden A, Adachi M. Neutrophilic airway inflammation and IL-17. Allergy 2002; 57:769-75.
20. Ruddy MJ, Shen F, Smith JB, Sharma A, Gaffen SL. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol 2004; 76:135-44.
21. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15:749-95.
22. Vanbervliet B, Bendriss-Vermare N, Massacrier C, Homey B, de Bouteiller O, Briere F, Trinchieri G, Caux C. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med 2003; 198:823-30.
23. Balch SG, Greaves DR, Gordon S, McKnight AJ. Organization of the mouse macrophage C-type lectin (Mcl) gene and identification of a subgroup of related lectin molecules. Eur J Immunogenet 2002; 29:61-4.
24. Flornes LM, Bryceson YT, Spurkland A, Lorentzen JC, Dissen E, Fossum S. Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex. Immunogenetics 2004; 56:506-17.
25. Arce I, Martinez-Munoz L, Roda-Navarro P, Fernandez-Ruiz E. The human C-type lectin CLECSF8 is a novel monocyte/macrophage endocytic receptor. Eur J Immunol 2004; 34:210-20.
26. Bin LH, Nielson LD, Liu X, Mason RJ, Shu HB. Identification of uteroglobin-related protein 1 and macrophage scavenger receptor with collagenous structure as a lung-specific ligand-receptor pair. J Immunol 2003; 171:924-30.
27. Zhou JS, Friend DS, Feldweg AM, Daheshia M, Li L, Austen KF, Katz HR. Prevention of lipopolysaccharide-induced microangiopathy by gp49B1: evidence for an important role for gp49B1 expression on neutrophils. J Exp Med 2003; 198:1243-51.
28. Lee KM, McNerney ME, Stepp SE, Mathew PA, Schatzle JD, Bennett M, Kumar V. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med 2004; 199:1245-54.
29. Takai T, Ono M. Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family. Immunol Rev 2001; 181:215-22.
30. Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol 2003; 3:445-53.
31. Boone DL, Turer EE, Lee EG et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004; 5:1052-60.
32. Munford RS, Hunter JP. Acyloxyacyl hydrolase, a leukocyte enzyme that deacylates bacterial lipopolysaccharides, has phospholipase, lysophospholipase, diacylglycerollipase, and acyltransferase activities in vitro. J Biol Chem 1992; 267:10116-21.
33. Dawson TC, Lentsch AB, Wang Z, Cowhig JE, Rot A, Maeda N, Peiper SC. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000; 96:1681-4.
34. Fujii J, Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 2002; 7:123-30.
35. Ushikubi F, Segi E, Sugimoto Y et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 1998; 395:281-4.
36. Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, Ehrenstein MR, Walport MJ, Botto M. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 2002; 99:16969-74.
37. Hashimoto K. Regulation of keratinocyte function by growth factors. J Dermatol Sci 2000; 24:S46-50.
38. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 2003; 4:721-32.
39. Kruetzmann S, Rosado MM, Weber H et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003; 197:939-45.
40. Baumgarth N, Chen J, Herman OC, Jager GC, Herzenberg LA. The role of B-1 and B-2 cells in immune protection from influenza virus infection. Curr Top Microbiol Immunol 2000; 252:163-9.
41. Kretschmer U, Bonhagen K, Debes GF et al. Expression of selectin ligands on murine effector and IL-10-producing CD4(+) T cells from non-infected and infected tissues. Eur J Immunol 2004; 34:3070-81.
42. Carsetti R, Rosado MM, Donnanno S et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005; 115:412-17.
43. Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE. Interleukin (IL) -1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem 2004; 279:13677-88.
44. Gibot S, Kolopp-Sarda MN, Bene MC, Cravoisy A, Levy B, Faure GC, Bollaert PE. Plasma level of a triggering receptor expressed on myeloid cells. 1: Its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004; 141:9-15.
45. Richeldi L, Mariani M, Losi M et al. Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 2004; 24:247-50.
46. Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, Ishii S, van der Poll T. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis 2004; 189:711-16.
47. Kaetzel CS. Polymeric Ig receptor: defender of the fort or Trojan horse? Curr Biol 2001; 11:R35-8.
48. van der Poll T. Coagulation and inflammation. J Endotoxin Res 2001; 7:301-4.
49. Gunther A, Mosavi P, Heinemann S et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161:454-62.